Fabbri, Leonardo M.
Kerwin, Edward M.
Spangenthal, Selwyn
Ferguson, Gary T.
Rodriguez-Roisin, Roberto
Pearle, James
Sethi, Sanjay
Orevillo, Chad
Darken, Patrick
St. Rose, Earl
Fischer, Tracy
Golden, Michael
Dwivedi, Sarvajna
Reisner, Colin
Funding for this research was provided by:
Pearl Therapeutics Inc., a member of the AstraZeneca Group (N/A)